Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Cardiometabolism in Health and Disease

Award Number: R13HL184864
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 01/21/2026
PERIOD OF PERFORMANCE END DATE: 12/31/2026

Group Awards By:

View Award Description

Cardiometabolism in Health and Disease - Abstract Support is requested for a Keystone Symposia conference entitled “Cardiometabolism in Health and Disease,” organized by Drs. Daniel P. Kelly, Rong Tian and William C. Sessa, with scientific programming input from Keystone Symposia. The meeting will take place January 26–29, 2026 at the Keystone Resort in Keystone, Colorado. There has been a groundbreaking surge in knowledge regarding the intertwined health challenges of obesity and cardiovascular disease. Cardiovascular outcomes in recent trials have unveiled an extraordinary, though not fully understood, cardioprotective effect of diabetes and obesity medications. Concurrently, innovative technologies now enable comprehensive real-time analysis of systemic, organ, and cellular metabolism under these treatment regimes. This Keystone Symposia meeting will delve into critical topics in cardiometabolism in both health and disease, including the metabolic foundations of heart and vascular health/disease; the interplay between organs that underpins the synergy among obesity, insulin resistance, and cardiovascular disease; the mechanisms by which new drugs, such as SGLT2 inhibitors and GLP-1 receptor agonists, mitigate cardiovascular events; and the influence of environmental factors, such as diet and circadian rhythms, on cardiovascular health and disease. Conference sessions will highlight presentations from global experts and encourage interactive discussions relevant to the understanding and treatment of the growing unmet health problem of heart and vascular disease in the growing population of patients with obesity and diabetes. Additionally, this conference has been paired with another Keystone Symposia conference, “Obesity Therapeutics: Unlocking Benefits and Minimizing Side Effects,” and will present groundbreaking research from both basic and translational science on the treatment of obesity and cardiometabolic disease. In this regard, this pairing provides greater opportunities for cross-fertilization of ideas and the initiation of novel research directions and collaborations among a multidisciplinary group of leading researchers.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $18,100 )
2026	2026	KEYSTONE SYMPOSIA ON MOLECULAR AND CELLULAR BIOLOGY	160 HWY 6 STE 201	SILVERTHORNE	CO	80498	SUMMIT	USA	Cardiovascular Diseases Research	000	1	1/21/2026	NEW	$18,100
														Subtotal = $18,100

Grand Total All Awards = $18,100

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Cardiometabolism in Health and Disease

Award Number: R13HL184864

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 01/21/2026

PERIOD OF PERFORMANCE END DATE: 12/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer